On July 13, 2016, the United States Senate Judiciary Subcommittee on Crime and Terrorism held a hearing to review the benefits and risks of medical marijuana.
Capitol Hearings, a service of C-Span, taped the hearing (see below), “Researching the Potential Medical Benefits and Risks of Marijuana.” The hearing’s schedule of witnesses is as follows:
- Panel 1 – Sens. Kirsten Gillibrand, D-N.Y., and Cory Booker, D-N.J.
- Panel 2 – Dr. Susan Weiss, Ph.D., Director of the National Institute On Drug Abuse’s Division Of Extramural Research, and Dr. Douglas Throckmorton, M.D., Deputy Center Director of the Food And Drug Administration’s Regulatory Programs.
- Panel 3 – Dr. Daniele Piomelli, Ph.D., Pharm.D., Professor Of Anatomy And Neurobiology at the UC-Irvine, Dr. Stuart Gitlow, M.D., Executive Director of American Society Of Addiction Medicine’s Annenberg Physician Training Program In Addictive Disease, and Mr. D. Linden Barber, J.D., Partner at Quarles and Brady, LLP.
According to NORML, this hearing follows the introduction of House Bill 5549, which would amend the Controlled Substances Act so qualified medical marijuana researchers could have access to marijuana, as well as the introduction of similar legislation in the Senate, Senate Bill 3077.
via MJNews and YouTube